Silence Therapeutics plc — Investor Relations & Filings
Silence Therapeutics plc is a clinical-stage biotechnology company pioneering the design and development of medicines based on short-interfering RNA (siRNA). The company utilizes its proprietary technology platform to create precision-engineered therapies that selectively silence the expression of disease-causing genes. Its clinical pipeline focuses on addressing conditions with high unmet medical needs in therapeutic areas such as cardiovascular disease, hematology, and rare diseases. Key product candidates in development include zerlasiran, targeting cardiovascular risk, and divesiran for polycythemia vera. The company aims to provide transformative treatments for patients who have limited or inadequate therapeutic options.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B5 | 2026-05-27 | English | |
| 8-K | 2026-05-18 | English | |
| S-3 | 2026-05-18 | English | |
| 10-Q - Silence Therapeutics plc (0001479615) (Filer) | 2026-05-07 | English | |
| 8-K - Silence Therapeutics plc (0001479615) (Filer) | 2026-05-07 | English | |
| DEF 14A - Silence Therapeutics plc (0001479615) (Filer) | 2026-04-29 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
13 filings
| |||||
| 47845598 | 424B5 | 2026-05-27 | English | ||
| 46471553 | 8-K | 2026-05-18 | English | ||
| 46459318 | S-3 | 2026-05-18 | English | ||
| 42935560 | 10-Q - Silence Therapeutics plc (0001479615) (Filer) | 2026-05-07 | English | ||
| 42920829 | 8-K - Silence Therapeutics plc (0001479615) (Filer) | 2026-05-07 | English | ||
| 38814904 | DEF 14A - Silence Therapeutics plc (0001479615) (Filer) | 2026-04-29 | English | ||
| 32892482 | 4 - SILENCE THERAPEUTICS PLC (0001479615) (Filer) | 2026-02-13 | English | ||
| 17980950 | SCHEDULE 13G/A - Silence Therapeutics plc (0001479615) (Subject) | 2026-02-09 | English | ||
| 12332204 | Director's Dealing 2026 | 2026-01-06 | English | ||
| 12332206 | Director's Dealing 2026 | 2026-01-06 | English | ||
| 12332207 | Director's Dealing 2026 | 2026-01-06 | English | ||
| 12332209 | Director's Dealing 2026 | 2026-01-06 | English | ||
| 12332210 | Director's Dealing 2026 | 2026-01-06 | English | ||
|
2025
2 filings
| |||||
| 12332211 | Director's Dealing 2025 | 2025-12-23 | English | ||
| 12332212 | Director's Dealing 2025 | 2025-12-23 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Silence Therapeutics plc, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
Silence Therapeutics plc via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33536/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33536 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33536 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33536 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33536}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Silence Therapeutics plc (id: 33536)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.